PL361014A1 - Novel polymorphic form of 17-beta-(n-ter.butyl carbamoyl)-4-aza-5-alpha-androst-1-en-3-one and a process for preparing it - Google Patents

Novel polymorphic form of 17-beta-(n-ter.butyl carbamoyl)-4-aza-5-alpha-androst-1-en-3-one and a process for preparing it

Info

Publication number
PL361014A1
PL361014A1 PL01361014A PL36101401A PL361014A1 PL 361014 A1 PL361014 A1 PL 361014A1 PL 01361014 A PL01361014 A PL 01361014A PL 36101401 A PL36101401 A PL 36101401A PL 361014 A1 PL361014 A1 PL 361014A1
Authority
PL
Poland
Prior art keywords
androst
aza
ter
beta
alpha
Prior art date
Application number
PL01361014A
Other languages
Polish (pl)
Inventor
S.T. Rajan
M.V.N.Brahmeshwara Rao
S.Vishnuvardhana Reddy
K.Shashi Rekha
M.Satyanarayana Reddy
K. Vyas
Original Assignee
Dr.Reddy's Laboratories Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr.Reddy's Laboratories Ltd. filed Critical Dr.Reddy's Laboratories Ltd.
Publication of PL361014A1 publication Critical patent/PL361014A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
PL01361014A 2000-09-07 2001-06-19 Novel polymorphic form of 17-beta-(n-ter.butyl carbamoyl)-4-aza-5-alpha-androst-1-en-3-one and a process for preparing it PL361014A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN737DE2000 2000-09-07
PCT/US2001/019546 WO2002020553A1 (en) 2000-09-07 2001-06-19 NOVEL POLYMORPHIC FORM OF 17-β-(N-TER.BUTYL CARBAMOYL)-4-AZA-5-α-ANDROST-1-EN-3-ONE AND A PROCESS FOR PREPARING IT

Publications (1)

Publication Number Publication Date
PL361014A1 true PL361014A1 (en) 2004-09-20

Family

ID=11097081

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01361014A PL361014A1 (en) 2000-09-07 2001-06-19 Novel polymorphic form of 17-beta-(n-ter.butyl carbamoyl)-4-aza-5-alpha-androst-1-en-3-one and a process for preparing it

Country Status (12)

Country Link
EP (1) EP1322663A1 (en)
JP (1) JP2004508380A (en)
AU (1) AU6991101A (en)
BR (1) BR0113732A (en)
CA (1) CA2422159A1 (en)
HU (1) HUP0300937A3 (en)
IL (1) IL154785A0 (en)
NO (1) NO20031045L (en)
NZ (1) NZ525116A (en)
PL (1) PL361014A1 (en)
WO (1) WO2002020553A1 (en)
ZA (1) ZA200302554B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2206065B1 (en) * 2002-10-31 2005-08-16 Ragactives, S.L. PROCEDURE FOR OBTAINING THE POLYMORPHIC FORM I OF FINASTERIDA.
ATE406376T1 (en) * 2003-07-03 2008-09-15 Cipla Ltd METHOD FOR PRODUCING FINASTERIDE FORM I
CN1294913C (en) * 2004-12-23 2007-01-17 鲁南制药集团股份有限公司 Medication combination of containing finasteride and cyclodextrin or ramification

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225100A (en) * 1987-06-29 1991-09-25 Merck & Co Inc Reaction of steroids (including 4-azasteroids) with a silylating agent in the presence of a quinone to introduce a delta' double bond and silylated intermediates
US5237061A (en) * 1988-10-31 1993-08-17 Merck & Co., Inc. Methods of synthesizing benign prostatic hypertropic agents and their intermediates
US5021575A (en) * 1989-11-13 1991-06-04 Merck & Co., Inc. Method for introducing a 1,2 double bond into azasteroids
US5091534A (en) * 1990-08-27 1992-02-25 Merck & Co., Inc. Trialkylsilyl trifluoromethanesulfonate mediated α-methylenic carbon functionalization of 4-AZA-5α-androstan-3-one steroids
US5468860A (en) * 1992-11-19 1995-11-21 Merck & Co., Inc. New finasteride processes

Also Published As

Publication number Publication date
EP1322663A1 (en) 2003-07-02
NO20031045L (en) 2003-04-29
WO2002020553A1 (en) 2002-03-14
NO20031045D0 (en) 2003-03-06
NZ525116A (en) 2004-11-26
HUP0300937A2 (en) 2007-02-28
CA2422159A1 (en) 2002-03-14
AU6991101A (en) 2002-03-22
JP2004508380A (en) 2004-03-18
ZA200302554B (en) 2004-02-19
IL154785A0 (en) 2003-10-31
HUP0300937A3 (en) 2007-10-29
BR0113732A (en) 2003-07-29

Similar Documents

Publication Publication Date Title
AP2003002757A0 (en) Process and intermediates for preparing anticancer compounds
ZA200108623B (en) Process for preparing imidachloprid.
AU2001242861A1 (en) Chain extension process
HUP0301649A3 (en) Process for preparing azacycloalkanoylaminothiazoles
HUP0300114A3 (en) Process for preparing flavonoid-derivatives
GB2375974B (en) A process for the preparation of 1, 1, 1, 2-tetrafluoroethane
AUPR503101A0 (en) Improved leaching process
AU6991101A (en) Novel polymorphic form of 17-beta-(n-ter.butyl carbamoyl)-4-aza-5-alpha-androst-1-en-3-one and a process for preparing it
MXPA03005569A (en) New process.
AU2002240036A1 (en) Improved printing process
AU2001280244A1 (en) Novel process for preparing 3-aminomethyl-4-z-methoxyiminopyrrolidine
AU2001267769A1 (en) Process
AU2001271913A1 (en) Process guru
GB0021066D0 (en) Novel process
AU2001281892A1 (en) Process for preparing flavour compounds
AU2001272549A1 (en) Extraction process
AU2002212582A1 (en) Process for preparing (-)- menthol and similar compounds
GB0025616D0 (en) Novel process
GB0013487D0 (en) Novel process
HK1031881A1 (en) Process for preparing 8-cyclopentyl-6-ethyl-3-Äsu bstitutedÜ-5,8-dihydro-4H-1,2,3A, 7,8-pentaaza-as-indacenes and intermediates useful therein.
AU2001234795A1 (en) Process for obtaining 1, 2, 3, 5, 6, 7, 8, 8a-oltahydro-1, 2, 8, 8tetramethylnaphthalen-2-yl!etan-1-one
AU2001230250A1 (en) Method for synthesizing 2,2,4,4-tetrasubstituted 1,3,5-cyclohexane trions
AU2001261564A1 (en) Process for preparing cis-aminochromanols
GB0028697D0 (en) Novel process
AU2001286392A1 (en) Process for preparing 2-phenyl-3-aminobenzothiophenes

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)